INVA

$0.00

(

+0.00%

)
Quote details

stock

Innoviva Inc

NASDAQ | INVA

20.61

USD

+0.00

(

+0.00%

)

AT CLOSE (AS OF Aug 13, 2025)

$1.3B

MARKET CAP

35.25

P/E Ratio

0.57

EPS

$22

52 Week High

$17

52 Week Low

LIFE SCIENCES

Sector

INVA Chart

Recent Chart
Price Action
1D
Candles

Trade Smarter

Automate your trading workflow with powerful tools — built for serious traders.

Icon For Time-schedule

Backtests

Strategy Backtester designed to automate your backtesting and revolutionize the way you trade

Icon For Search

Scanner

Leverage the power of AI to detect valuable opportunities and gain the most out of the markets.

Signals

Automate your trading workflow with AI-powered trading signals to execute trades automatically.

Icon For Clipboard-list

Journal

Record your trades and performance to improve your trading with AfterPullback's Trading Journal

INVA Technicals

Tags:

INVA Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $322M
Total Revenue $359M
Cost Of Revenue $37M
Costof Goods And Services Sold $37M
Operating Income $167M
Selling General And Administrative $116M
Research And Development $14M
Operating Expenses $155M
Investment Income Net -
Net Interest Income -$3.1M
Interest Income $19M
Interest Expense $22M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $40M
Income Before Tax $37M
Income Tax Expense $14M
Interest And Debt Expense -
Net Income From Continuing Operations $23M
Comprehensive Income Net Of Tax -
Ebit $60M
Ebitda $99M
Net Income $23M

Revenue & Profitability

Earnings Performance

INVA Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $1.3B
Total Current Assets $554M
Cash And Cash Equivalents At Carrying Value $305M
Cash And Short Term Investments $305M
Inventory $34M
Current Net Receivables $86M
Total Non Current Assets $747M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $208M
Intangible Assets Excluding Goodwill $208M
Goodwill $18M
Investments -
Long Term Investments $394M
Short Term Investments $108M
Other Current Assets $22M
Other Non Current Assets -
Total Liabilities $610M
Total Current Liabilities $236M
Current Accounts Payable $2.1M
Deferred Revenue -
Current Debt -
Short Term Debt $194M
Total Non Current Liabilities $374M
Capital Lease Obligations $2.8M
Long Term Debt $256M
Current Long Term Debt $192M
Long Term Debt Noncurrent -
Short Long Term Debt Total $451M
Other Current Liabilities -$14M
Other Non Current Liabilities -
Total Shareholder Equity $691M
Treasury Stock -
Retained Earnings -$1.8M
Common Stock $627K
Common Stock Shares Outstanding $74M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow $189M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $40M
Capital Expenditures $270K
Change In Receivables -
Change In Inventory $14M
Profit Loss -
Cashflow From Investment -$64M
Cashflow From Financing -$13M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$15M
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income $23M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $322M
Total Revenue $359M
Cost Of Revenue $37M
Costof Goods And Services Sold $37M
Operating Income $167M
Selling General And Administrative $116M
Research And Development $14M
Operating Expenses $155M
Investment Income Net -
Net Interest Income -$3.1M
Interest Income $19M
Interest Expense $22M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $40M
Income Before Tax $37M
Income Tax Expense $14M
Interest And Debt Expense -
Net Income From Continuing Operations $23M
Comprehensive Income Net Of Tax -
Ebit $60M
Ebitda $99M
Net Income $23M

Dividends

Field Value
Ex Dividend Date 2015-09-08
Declaration Date None
Record Date None
Payment Date None
Amount 0.25

INVA News

INVA Profile

Innoviva Inc Profile

Sector: LIFE SCIENCES

Industry: PHARMACEUTICAL PREPARATIONS

Innoviva, Inc. is dedicated to the development and commercialization of pharmaceutical products. The company is headquartered in Burlingame, California.

Discover more tools and features to empower your trading
Explore Features

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.